These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28692320)

  • 1. The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis.
    Isidro RA; Lopez A; Cruz ML; Gonzalez Torres MI; Chompre G; Isidro AA; Appleyard CB
    J Histochem Cytochem; 2017 Aug; 65(8):445-461. PubMed ID: 28692320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifidobacterium longum and VSL#3
    Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
    Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.
    Mennigen R; Nolte K; Rijcken E; Utech M; Loeffler B; Senninger N; Bruewer M
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1140-9. PubMed ID: 19221015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice.
    Kumar M; Kissoon-Singh V; Coria AL; Moreau F; Chadee K
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G34-G45. PubMed ID: 27856417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis.
    Uronis JM; Arthur JC; Keku T; Fodor A; Carroll IM; Cruz ML; Appleyard CB; Jobin C
    Inflamm Bowel Dis; 2011 Jan; 17(1):289-97. PubMed ID: 20564535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer.
    Appleyard CB; Cruz ML; Isidro AA; Arthur JC; Jobin C; De Simone C
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1004-13. PubMed ID: 21903764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties.
    Biagioli M; Capobianco D; Carino A; Marchianò S; Fiorucci C; Ricci P; Distrutti E; Fiorucci S
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30717413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
    Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
    mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice.
    Gaudier E; Michel C; Segain JP; Cherbut C; Hoebler C
    J Nutr; 2005 Dec; 135(12):2753-61. PubMed ID: 16317116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable response to probiotics in two models of experimental colitis in rats.
    Shibolet O; Karmeli F; Eliakim R; Swennen E; Brigidi P; Gionchetti P; Campieri M; Morgenstern S; Rachmilewitz D
    Inflamm Bowel Dis; 2002 Nov; 8(6):399-406. PubMed ID: 12454615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications.
    Hörmannsperger G; Clavel T; Hoffmann M; Reiff C; Kelly D; Loh G; Blaut M; Hölzlwimmer G; Haller D
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S10-5. PubMed ID: 20562631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis.
    Chen G; Yang Y; Gao X; Dou Y; Wang H; Han G; Wang R; Wang J; Wang L; Li X; Guo R; Xiao H; Shen B; Li Y
    Lab Invest; 2011 Mar; 91(3):472-83. PubMed ID: 21102504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Probiotic Mixture VSL#3 Alters the Morphology and Secretion Profile of Both Polarized and Unpolarized Human Macrophages in a Polarization-Dependent Manner.
    Isidro RA; Bonilla FJ; Pagan H; Cruz ML; Lopez P; Godoy L; Hernandez S; Loucil-Alicea RY; Rivera-Amill V; Yamamura Y; Isidro AA; Appleyard CB
    J Clin Cell Immunol; 2014 Jun; 5(3):1000227. PubMed ID: 25177525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice.
    Zhao HM; Huang XY; Zuo ZQ; Pan QH; Ao MY; Zhou F; Liu HN; Liu ZY; Liu DY
    World J Gastroenterol; 2013 Feb; 19(5):742-9. PubMed ID: 23430765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics.
    Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L
    Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Bacillus subtilis PB6, a natural probiotic on colon mucosal inflammation and plasma cytokines levels in inflammatory bowel disease.
    Selvam R; Maheswari P; Kavitha P; Ravichandran M; Sas B; Ramchand CN
    Indian J Biochem Biophys; 2009 Feb; 46(1):79-85. PubMed ID: 19374258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis implicating regulation of energy metabolism.
    Jiang XG; Sun K; Liu YY; Yan L; Wang MX; Fan JY; Mu HN; Li C; Chen YY; Wang CS; Han JY
    Sci Rep; 2017 Feb; 7():41832. PubMed ID: 28150820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactic Acid Bacteria Isolated from Human Breast Milk Improve Colitis Induced by 2,4,6-Trinitrobenzene Sulfonic Acid by Inhibiting NF-κB Signaling in Mice.
    Kim KJ; Kyung S; Jin H; Im M; Kim JW; Kim HS; Jang SE
    J Microbiol Biotechnol; 2023 Aug; 33(8):1057-1065. PubMed ID: 37280778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.
    Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J
    World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis.
    Peran L; Sierra S; Comalada M; Lara-Villoslada F; Bailón E; Nieto A; Concha A; Olivares M; Zarzuelo A; Xaus J; Gálvez J
    Br J Nutr; 2007 Jan; 97(1):96-103. PubMed ID: 17217564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.